Skip to main content
OpenTrials

Clinical trial condition

Hormone-sensitive, HER-2 Negative Metastatic Breast Cancer

Explore clinical trials studying Hormone-sensitive, HER-2 Negative Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Hormone-sensitive, HER-2 Negative Metastatic Breast Cancer trial results

Completed

Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast Cancer

NCT01446159

Conditions
Breast Diseases, Breast Neoplasms, Hormone-sensitive, HER-2 Negative Metastatic Breast Cancer, +8 more
Locations
  • Research Site Scottsdale, Arizona, United States
  • Research Site Bakersfield, California, United States
  • Research Site Pleasant Hill, California, United States
  • Research Site Stamford, Connecticut, United States
View all 71 locations
View Trial Details

Related conditions